IRB #
STUDY00019992
Title
[NCI CIRB] MATCH - EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Principal Investigator
Christopher Ryan
Study Purpose
The purpose of this trial is to establish whether participants with specific gene changes or mutations are likely to benefit if treated with study drugs targeting the genetic pathway.
Medical Condition(s)
Bladder cancer
Breast cancer
Cervical cancer
Colorectal cancer
Glioblastoma (GBM)
Glioma
Head and neck cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreas cancer
Prostate cancer
Stomach cancer
Thyroid cancer
Uterine cancer
Eligibility Criteria
- Participants must have documented solid tumors, lymphoma, or multiple myeloma
- Participants must have progressed following at least 1 line of standard treatment
- Participants must receive lab results indicating a "rare variant" of interest for the study
Age Range
18 - 100
Healthy Volunteers Needed
No
Duration of Participation
Participants will be on study for up to 3 years from the time of study entry through follow up.
Minors Included
No
Contact
Knight Information Line - trials@ohsu.edu or 503-494-1080
Sponsor
ECOG-ACARIN
Recruitment End
06/30/2022
Compensation Provided
No
Go Back